These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34762778)

  • 1. Measuring visfatin levels in saliva: an alternative approach to gestational diabetes screening.
    Eroglu Içli H; Bildaci TB
    Arch Endocrinol Metab; 2021 Nov; 65(6):747-751. PubMed ID: 34762778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Leptin and Chemerin; a novel way of gestational diabetes screening.
    Okten SB; Bildacı TB
    Gynecol Endocrinol; 2020 Dec; 36(12):1116-1118. PubMed ID: 32274942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
    Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus.
    Karatas A; Tunçay Işikkent N; Ozlü T; Demirin H
    Gynecol Endocrinol; 2014 May; 30(5):355-8. PubMed ID: 24512558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.
    Lewandowski KC; Stojanovic N; Press M; Tuck SM; Szosland K; Bienkiewicz M; Vatish M; Lewinski A; Prelevic GM; Randeva HS
    Diabetologia; 2007 May; 50(5):1033-7. PubMed ID: 17334748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.
    Mazaki-Tovi S; Romero R; Kusanovic JP; Vaisbuch E; Erez O; Than NG; Chaiworapongsa T; Nhan-Chang CL; Pacora P; Gotsch F; Yeo L; Kim SK; Edwin SS; Hassan SS; Mittal P
    J Perinat Med; 2009; 37(3):218-31. PubMed ID: 19099366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased visfatin concentrations in women with gestational diabetes mellitus.
    Krzyzanowska K; Krugluger W; Mittermayer F; Rahman R; Haider D; Shnawa N; Schernthaner G
    Clin Sci (Lond); 2006 May; 110(5):605-9. PubMed ID: 16489932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus.
    Kaygusuz I; Gumus II; Yılmaz S; Simavlı S; Uysal S; Derbent AU; Gözdemir E; Kafalı H
    Gynecol Obstet Invest; 2013; 75(3):203-9. PubMed ID: 23548246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis.
    Jiang YK; Deng HY; Qiao ZY; Gong FX
    Arch Physiol Biochem; 2021 Oct; 127(5):468-478. PubMed ID: 33476191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of visfatin in pathogenesis of gestational diabetes (GDM).
    Radzicka S; Pietryga M; Iciek R; Brązert J
    Ginekol Pol; 2018; 89(9):518-521. PubMed ID: 30318580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester.
    Akturk M; Altinova AE; Mert I; Buyukkagnici U; Sargin A; Arslan M; Danisman N
    J Endocrinol Invest; 2008 Jul; 31(7):610-3. PubMed ID: 18787378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus.
    Coskun A; Ozkaya M; Kiran G; Kilinc M; Arikan DC
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1014-8. PubMed ID: 20059442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus.
    Ferreira AF; Rezende JC; Vaikousi E; Akolekar R; Nicolaides KH
    Clin Chem; 2011 Apr; 57(4):609-13. PubMed ID: 21325104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis.
    Zhang W; Zhao D; Meng Z; Wang H; Zhao K; Feng X; Li Y; Dun A; Jin X; Hou H
    Acta Diabetol; 2018 Nov; 55(11):1113-1120. PubMed ID: 29992461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary visfatin concentrations in patients with chronic periodontitis.
    Tabari ZA; Azadmehr A; Nohekhan A; Naddafpour N; Ghaedi FB
    J Periodontol; 2014 Aug; 85(8):1081-5. PubMed ID: 24228809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of visfatin in the pathogenesis of gestational diabetes mellitus.
    Gok DE; Yazici M; Uckaya G; Bolu SE; Basaran Y; Ozgurtas T; Kilic S; Kutlu M
    J Endocrinol Invest; 2011 Jan; 34(1):3-7. PubMed ID: 20220292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparing two screening policies of gestational diabetes mellitus: The Mohammed V Training Military Hospital of Rabat (Morocco)].
    Bouhsain S; El Kochri S; Babahabib MA; Hafidi MH; Bouaiti E; Moussaoui MD
    Gynecol Obstet Fertil; 2014 May; 42(5):317-21. PubMed ID: 24411342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of visfatin in placenta in women with gestational diabetes mellitus].
    Luo JX; Liu XH; Zhang L; He GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):204-7. PubMed ID: 21500554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
    Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
    Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokine levels in overweight women with early-onset gestational diabetes mellitus.
    Lobo TF; Torloni MR; Mattar R; Nakamura MU; Alexandre SM; Daher S
    J Endocrinol Invest; 2019 Feb; 42(2):149-156. PubMed ID: 29696612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.